Boston's resTORbio Sets Terms for $85M IPO Post author:Sam Post published:January 16, 2018 Post category:BioPharma resTORbio is developing novel therapies to improve immune function in the elderly. Source: BioSpace You Might Also Like LakePharma Initiates Key Technology Resource Networks May 1, 2017 Biotech Startup Bonanza Continues as Emerges With $30 Million September 18, 2017 ContraVir Announces Pricing Of Public Offering Of Common Stock And Warrants April 24, 2017
